Abiomed acquires Breethe to expand ECMO product portfolio

Abiomed, maker of the Impella heart pump, acquired Breethe, developer of a novel ECMO system, to complement its product portfolio for patients with respiratory failure.

“Abiomed has acquired Breethe, developer of a novel extracorporeal membrane oxygenation (ECMO) system that will complement and expand Abiomed's product portfolio.”businesswire.com

• 2 sources
• businesswire.comAbiomed Expands Product Portfolio with Acquisition of Cardiopulmonary Support Technology (ECMO) to Improve Outcomes for PatientsSarah KarrApr 29, 2020
• technical.lyUMB-born medical device company Breethe acquired by AbiomedStephen BabcockMay 1, 2020

Summarized from public sources; check the original articles before acting on it.